Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001347

Drug Information
NameAntazoline    
SynonymsDivK1c_000083; Antazolina; KBioGR_000582; Antazolina [Spanish]; Imidamin; 5512-M; 2-(N-Phenyl-N-benzylaminomethyl)imidazoline; 154-68-7 (phosphate (1:1)); DB08799; KBio2_001269; 91-75-8; KBio1_000083; Tocris-0791; Azalone; IDI1_000083; BPBio1_000084; KBioSS_001269; NCGC00023164-03; Antihistal; KBio3_001366; Spectrum2_001259; Antazolinum [Latin]; Prestwick2_000258; D07458; N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline; SPBio_002295; NINDS_000083; HSDB 6506; NCGC00016613-01; BRN 0233924; N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-N-(phenylmethyl)aniline; CHEMBL1305; Antistine; CID2200; Antazolinum; antazoline; Antazoline (INN); 2-Phenyl-benzyl-amino-methylimidazolin; AC1L1D5C; 2508-72-7 (hydrochloride); NCGC00016613-03; LS-79572; Spectrum_000789; Spectrum4_000141; Antazoline [INN:BAN]; Antasten; EINECS 202-094-0; 2-Imidazoline, 2-((N-benzylanilino)methyl)-; Phenazoline; Analergine; 2-(N-Benzylanilinomethyl)-2-imidazoline; 1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)-; Spectrum5_000818; BSPBio_000076; KBio2_006405; KBio2_003837; Antazolinum [INN-Latin]; ST086981; Imidamine; C17H19N3; Antazolin; Histostab; CAS-2508-72-7; Prestwick1_000258; Antastan; Antazolina [INN-Spanish]; Phenazolin; L000841; UNII-DHA8014SS1; BRD-K99300445-011-02-9; Ben-A-hist; Spectrum3_000303; Prestwick0_000258; NCGC00016613-02; BRD-K99300445-003-03-4; 2-Phenyl-benzyl-amino-methylimidazolin [German]; Prestwick3_000258; 5-25-09-00364 (Beilstein Handbook Reference); 4,5-Dihydro-N-phenyl-N-phenylmethyl-1H-imidazole-2-methanamine; SPBio_001198; Antistin; BSPBio_001866    
IndicationNasal congestionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassCentral Nervous System Agents    
CAS NumberCAS 91-75-8
FormularC17H19N3    
PubChem Compound IDCID 2200.    
PubChem Substance IDSID 150094.    
SuperDrug ATC IDR01AC04;    
SuperDrug CAS ID000091758;    
TargetHistamine H1 receptorAntagonist[2][3][4][5]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018746 To Reference
Ref 2Histamine and the convulsive threshold or effectiveness of antiepileptic drugs. Przegl Lek. 2008;65(11):803-6. To Reference
Ref 3Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol. 2004 Aug;14(4):307-18. To Reference
Ref 4A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Acta Ophthalmol Scand Suppl. 1999;(228):33-7. To Reference
Ref 5Nonsedating histamine H1-receptor antagonists. Clin Pharm. 1989 May;8(5):331-44. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543